Skip to main content

Table 2 Sample Characteristics

From: Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children

 

Children participating in the OX-NDA evaluation study

(n = 104)

Mean (SD) or number (%)

Children in the Pelotas 2015 Birth Cohort not participating in the OX-NDA evaluation study

(n = 3914)

Mean (SD) or number (%)

p value

Socio-demographic, prenatal and perinatal characteristics

 Maternal age at recruitment, years

27.1 (6.6)

27.5 (6.2)

0.51

 Monthly family income

3585.6 (5667.7)

3010.9 (4377.3)

0.55

 Duration of mother’s formal education, years

10.1 (4.0)

10.7 (4.0)

0.09

 Maternal employment status

49 (47.1%)

1878 (47.9%)

0.06

 Maternal infections (including HIV, rubella, syphilis, hepatitis B, CMV, toxoplasmosis, tuberculosis and malaria)

10.0 (11.6%)

348 (9.6%)

0.49

 Maternal substance abuse (including alcohol) and smoking

20 (19.2%)

582 (16.1%)

0.18

 Maternal prenatal anxiety and depression/mental stress

15 (14.4%)

402 (11.1%)

0.26

 Maternal preeclampsia and eclampsia

10 (9.6%)

227 (6.3%)

0.10

Perinatal and Neonatal characteristics

 Gestational age at delivery, weeks

38.7 (2.0)

38.4 (2.4)

0.34

 Birth weight, kg

3.2 (0.5)

3.2 (0.5)

0.39

 Birth length, cm

48.3 (2.6)

40.2 (3.2)

0.64

 Head circumference at birth, cm

33.9 (1.5)

33.9 (2.9)

0.94

 Apgar score at 5 min

9.5 (0.6)

9.7 (4.3)

0.13

 Boys

55 (53.0%)

1848 (51.1%)

0.72

Postnatal characteristics

 Only child

51 (49.0%)

1905 (48.7%)

0.95

 Mean age of 12-month / OX-NDA assessment (days)

367.6 (8.4)

 Significant morbidity during the first year of life1

4 (3.8%)

153 (5.1%)

0.73

 Weight at 1 year, kg

10.1 (1.2)

9.9 (1.4)

0.28

 Length at 1 year, cm

75.1 (3.1)

75.0 (3.0)

0.63

 Immunized for age

90 (100%)

2955 (99.7%)

0.60

 Age at which infant was weaned, months

5.7 (3.4)

4.1 (3.8)

*0.001

 BSID-III assessment conducted before OX-NDA

52 (50%)

 Duration between OX-NDA and BSID-III assessments at 1 year, day

1 (0)

  1. *p < 0.05
  2. OX-NDA The Oxford Neurodevelopment Assessment
  3. 1Signficant morbidity during the first year of life is defined as any life threatening or life altering condition, requiring prolonged hospitalization and/or treatment, such as epilepsy, metabolic disorders, endocrinological disorders, haematological disorders including haemophilia, oncological diagnosis, any conditions requiring surgery, congenital cardiac conditions, prolonged ventilation included home-based ventilatory support and/or neurological conditions requiring prolonged treatment and/or surveillance